CDR | KGT group (n = 16) | Placebo group (n = 14) | p-value‡ |
---|---|---|---|
Reversion to normal (CDR of 0.5 points → 0 points) | 5 (31.25%) | 2 (14.29%) | 0.399 |
Stable MCI (CDR of 0.5 points) | 11 (68.75%) | 12 (85.71%) | |
Conversion to dementia (CDR of 0.5 points → ≥1 point) | 0 (0%) | 0 (0%) |